Fed Circ finds another CardioNet patent-ineligible under Alice
02-11-2021
Fed Circuit backs Endo in Alice suit over oxymorphone patent
29-03-2019
MiniStocker / Shutterstock.com
There has been a significant drop in the number of patents invalidated due to so-called Alice challenges since Federal Circuit rulings in Berkheimer v HP, and Aatrix Software v Green Shades Software, according to a new report.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
patent validity, Alice, RPX, patent risk management, patent eligibility, patent infringement, Berkheimer, Aatrix, Cellspin
